Lilly anticounterfeit measures
Lilly is exploring use of radio frequency identification on its products in pilot programs as part of multi-pronged anticounterfeit strategy. Other measures include Canadian supply allocation program, direct-buying requirement for wholesalers, and establishment of a global product protection division. The company's Feb. 5 press release describing the measures will be submitted to House Energy & Commerce Committee as requested under its counterfeit drug investigation (1"The Pink Sheet" Jan. 19, 2004, p. 13). Lilly's Zyprexa, Cialis and insulin products have been the subject of counterfeit concerns...
You may also be interested in...
The House Energy & Commerce Committee is asking five brand-name drug manufacturers to submit information on their efforts to prevent counterfeiting
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.